CIK: 0001056807 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $2,466,912 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KYMR | KYMERA THERAPEUTICS INC | 5,502,710 | $311,453 | 12.6% | $32.29 | +39.7% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 3,974,913 | $185,628 | 7.5% | $31.23 | +25.4% | COM | 76155X100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,560,916 | $170,122 | 6.9% | $29.18 | +94.8% | COM | 74366E102 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $141,617 | 5.7% | $6.29 | +729.2% | CLASS A ORD | 61559X104 |
| — | CIDARA THERAPEUTICS INC | 1,414,165 | $135,420 | 5.5% | $51.89 | — | COM NEW | 171757206 |
| GHRS | GH RESEARCH PLC | 8,827,712 | $126,236 | 5.1% | $18.98 | -26.3% | ORDINARY SHARES | G3855L106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,495,290 | $109,620 | 4.4% | $27.38 | +132.2% | COM | 604749101 |
| XOMA | XOMA ROYALTY CORPORATION | 2,590,303 | $99,830 | 4.0% | $15.57 | +99.5% | COM NEW | 98419J206 |
| GPCR | STRUCTURE THERAPEUTICS INC | 3,203,917 | $89,710 | 3.6% | $31.43 | — | SPONSORED ADS | 86366E106 |
| KURA | KURA ONCOLOGY INC | 8,617,162 | $76,262 | 3.1% | $9.56 | -25.4% | COM | 50127T109 |
| SEPN | SEPTERNA INC | 4,015,790 | $75,537 | 3.1% | $18.24 | -28.0% | COM | 81734D104 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 1,161,249 | $72,799 | 3.0% | $27.27 | +63.5% | COM | 697947109 |
| NKTR | NEKTAR THERAPEUTICS | 1,276,595 | $72,638 | 2.9% | $33.10 | 0.0% | COM NEW | 640268306 |
| ZYME | ZYMEWORKS INC | 3,938,641 | $67,272 | 2.7% | $7.03 | +103.7% | COM | 98985Y108 |
| AXSM | AXSOME THERAPEUTICS INC | 486,757 | $59,117 | 2.4% | $85.51 | +31.7% | COM | 05464T104 |
| ACIU | AC IMMUNE SA | 19,822,436 | $57,287 | 2.3% | $4.49 | -49.8% | SHS | H00263105 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,574,288 | $57,194 | 2.3% | $33.11 | — | ADS | 45258D105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $51,847 | 2.1% | $37.66 | -84.1% | COM | 68062P106 |
| TYRA | TYRA BIOSCIENCES INC | 3,649,794 | $51,061 | 2.1% | $16.23 | -29.7% | COM | 90240B106 |
| ABVX | ABIVAX SA | 558,031 | $47,377 | 1.9% | $84.90 | — | SPONSORED ADS | 00370M103 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 5,660,132 | $41,942 | 1.7% | $6.80 | -22.1% | COM | 61225M102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,629,289 | $40,229 | 1.6% | $13.79 | -56.7% | COM | 35104E100 |
| STOK | STOKE THERAPEUTICS INC | 1,657,096 | $38,942 | 1.6% | $17.13 | 0.0% | COM | 86150R107 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $34,102 | 1.4% | $20.31 | -63.9% | COM | 230031106 |
| CELC | CELCUITY INC | 658,421 | $32,526 | 1.3% | $16.73 | +139.2% | COM | 15102K100 |
| XNCR | XENCOR INC | 2,740,141 | $32,142 | 1.3% | $20.61 | -57.9% | COM | 98401F105 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $25,927 | 1.1% | $5.96 | -11.0% | COM | 344174107 |
| ANNX | ANNEXON INC | 7,000,000 | $21,350 | 0.9% | $2.47 | +0.3% | COM | 03589W102 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $18,187 | 0.7% | $19.56 | — | COM | 760273102 |
| AVTX | AVALO THERAPEUTICS INC | 1,355,256 | $17,225 | 0.7% | $9.92 | -13.3% | COM NEW | 05338F306 |
| CMPX | COMPASS THERAPEUTICS INC | 4,750,000 | $16,625 | 0.7% | $3.16 | 0.0% | COM | 20454B104 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,387,863 | $16,502 | 0.7% | $21.15 | -37.3% | COM | G2545C104 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $16,300 | 0.7% | $4.95 | -41.0% | COM | 28617K101 |
| TCRX | TSCAN THERAPEUTICS INC | 5,226,074 | $9,511 | 0.4% | $2.41 | -26.6% | COM | 89854M101 |
| PEPG | PEPGEN INC | 1,915,000 | $8,847 | 0.4% | $1.61 | 0.0% | COM | 713317105 |
| XFOR | X4 PHARMACEUTICALS INC | 2,233,742 | $7,639 | 0.3% | $2.58 | 0.0% | COM NEW | 98420X202 |
| IMUX | IMMUNIC INC | 7,652,972 | $6,747 | 0.3% | $1.30 | -32.1% | COM | 4525EP101 |
| IMA | IMAGENEBIO INC | 802,102 | $6,537 | 0.3% | $13.25 | 0.0% | COM | 45175G207 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5,023 | 0.2% | $9.66 | — | ADS | 60853G106 |
| IVA | INVENTIVA SA | 686,040 | $3,972 | 0.2% | $13.70 | — | ADS | 46124U107 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $2,584 | 0.1% | $3.62 | +68.6% | COM NEW | 88032L605 |
| — | ESSA PHARMA INC | 11,668,473 | $2,229 | 0.1% | $2.79 | — | COM NEW | 29668H708 |
| SABS | SAB BIOTHERAPEUTICS INC | 932,697 | $1,875 | 0.1% | $5.45 | -58.6% | COM NEW | 78397T202 |
| FBRX | FORTE BIOSCIENCES INC | 65,350 | $980 | 0.0% | $11.57 | -0.5% | COM NEW | 34962G208 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $681 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $263 | 0.0% | $5.07 | — | COM NEW | H57830137 |